StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/304% below fair value
$29.94−0.54 (-1.76%)

Close on Nov 13, 2026Market cap $1.54BP/E –Yield 0.00%

Immunocore EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Immunocore's EPS for the twelve months ending Sep 30, 2026 was -$0.64. For fiscal 2025 it was -$0.71. The highest annual figure on record is -$0.71 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.71–
FY2024Dec 31, 2024-$1.02–
FY2023Dec 31, 2023-$1.13–
FY2022Dec 31, 2022-$1.15–
FY2021Dec 31, 2021-$4.24–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.28–
Q2 FY2026Jun 30, 2026-$0.02–
Q1 FY2026Mar 31, 2026$0.25+150.0%
Q4 FY2025Dec 31, 2025-$0.59–
Q3 FY2025Sep 30, 2025$0.00-100.0%
Q2 FY2025Jun 30, 2025-$0.20–
Q1 FY2025Mar 31, 2025$0.10–
Q4 FY2024Dec 31, 2024-$0.47–
Q3 FY2024Sep 30, 2024$0.17+750.0%
Q2 FY2024Jun 30, 2024-$0.23–
Q1 FY2024Mar 31, 2024-$0.49–
Q4 FY2023Dec 31, 2023-$0.40–
Q3 FY2023Sep 30, 2023$0.02–
Q2 FY2023Jun 30, 2023-$0.35–
Q1 FY2023Mar 31, 2023-$0.40–

More Immunocore figures

See a number that looks wrong?